Heidi S. Feiler

Biochemistry, Genetics and Molecular Biology · Life Sciences

34h-index23.4kcitations126works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(17), Bioinformatics and Genomic Networks(15), Computational Drug Discovery Methods(14), Gene expression and cancer classification(11), Telomeres, Telomerase, and Senescence(11)

Publications124 total

Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancer
Cell Reports·2025Open Access
NanoString GeoMx DSP TMA-TNP Phase 4 WTA assay v1
2023Open Access
Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancers
2023Open Access
Data from Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
2023Open Access
Supplementary Table S1 from Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
2023Open Access
Data from Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
2023Open Access
Supplementary Data from Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
2023Open Access
Supplementary Table S1 from Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
2023Open Access
Supplementary Data from Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
2023Open Access
Data from Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells
2023Open Access
Supplemental Figures 1 to 14 from Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells
2023Open Access
Data from Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells
2023Open Access
Supplemental Methods from Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells
2023Open Access
Supplemental Figures 1 to 14 from Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells
2023Open Access
Supplemental Figure Legends from Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells
2023Open Access
Supplemental Methods from Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells
2023Open Access
Supplemental Figure Legends from Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells
2023Open Access
Supplementary Table 1 from Immutable Functional Attributes of Histologic Grade Revealed by Context-Independent Gene Expression in Primary Breast Cancer Cells
2023Open Access
Supplementary Figure 1 from Molecular Distinctions between Stasis and Telomere Attrition Senescence Barriers Shown by Long-term Culture of Normal Human Mammary Epithelial Cells
2023Open Access
Data from Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Joe W. Gray(24), Kirk C. Wilhelmsen(14), Laura M. Heiser(13), Paul T. Spellman(12), James E. Korkola(10), Zhi Hu(8), Gordon B. Mills(8), Lakshmi R. Jakkula(7), Nicholas J. Wang(7), Nora Bayani(7), Koei Chin(6), Elmar Bucher(6), Safiyyah Ziyad(5), Peter K. Sorger(5), Mark Dane(5), Andrew J. Wyrobek(5), James V. Lee(5), Tiera Liby(5), Elizabeth Purdom(4), Terence P. Speed(4)